Compare ZYME & GEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ZYME | GEL |
|---|---|---|
| Founded | 2003 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil Refining/Marketing |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.9B |
| IPO Year | 2022 | 1996 |
| Metric | ZYME | GEL |
|---|---|---|
| Price | $23.23 | $18.03 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | ★ $32.75 | $19.50 |
| AVG Volume (30 Days) | ★ 484.1K | 262.9K |
| Earning Date | 03-30-2026 | 05-12-2026 |
| Dividend Yield | N/A | ★ 4.04% |
| EPS Growth | ★ 5.81 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,304,000.00 | ★ $2,912,770,000.00 |
| Revenue This Year | $63.10 | $12.12 |
| Revenue Next Year | $93.26 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 0.38 | ★ 43.60 |
| 52 Week Low | $9.03 | $11.87 |
| 52 Week High | $28.49 | $18.16 |
| Indicator | ZYME | GEL |
|---|---|---|
| Relative Strength Index (RSI) | 49.13 | 61.90 |
| Support Level | $22.22 | $16.21 |
| Resistance Level | $23.66 | N/A |
| Average True Range (ATR) | 0.84 | 0.51 |
| MACD | 0.15 | 0.00 |
| Stochastic Oscillator | 45.85 | 92.05 |
Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enables precise engineering of differentiated therapeutic product candidates. Its clinical candidate, zanidatamab, is a novel HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas.
Genesis Energy LP is a limited partnership company that focuses on the midstream segment of the crude oil and natural gas industry. It engages in providing services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are offshore pipeline transportation, sodium minerals, and sulfur services, onshore facilities and transportation, and marine transportation. It generates maximum revenue from the offshore pipeline transportation segment which conducts crude oil and natural gas pipeline transportation and handling operations in the Gulf of Mexico through its offshore pipeline transportation segment, which focuses on providing a suite of services to integrated and large independent energy companies.